ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,865, issued on Sept. 16, was assigned to CORELINK LLC (St. Louis).
"Implant trial with radiographically visible indicium" was invented by Adam MacMillan (Quincy, Mass.), Gerhart Suppiger (St. Louis) and Brett Smith (St. Louis).
According to the abstract* released by the U.S. Patent & Trademark Office: "An implant trial includes a trial body and an indicium disposed in the trial body. The trial body is positionable in a subject. The indicium is designed and constructed to indicate a parameter of the implant trial. The indicium is radiographically visible when the trial body is positioned in the subject. The implant trial may be a trial spacer for vertebrae."
The patent was filed...